An Educational Initiative for Pharmacists to Inform Patients about Pegylated-Interferon and Ribavirin Combination Therapy in the Outpatient Clinic
スポンサーリンク
概要
- 論文の詳細を見る
Hepatitis C virus (HCV) is a leading cause of liver disease in Japan. Standard care of pegylated-interferon alfa as monotherapy and in combination with oral ribavirin has been used for the treatment of chronic hepatitis C in outpatient clinics. However, such treatments are associated with patientsanxiety concerning high medical costs, adverse events, the burden of weekly hospital visits, the impact on attendance at work, and the eventual outcome of treatment.In this study, we investigated the impact on patients when a pharmacist-managed education program about interferon therapy was provided prior to their final acceptance of treatment. Educational intervention significantly reduced patients anxiety about medical costs (p=0.004), adverse events (p=0.001) and impact on work (p=0.002). Patients in both the treatment group and the no-treatment group rated each section of the education program as being necessary. The patients expected answers regarding their personal concerns about the treatment. They thought it necessary that information such as that regarding severe adverse events should be explained by a pharmacist.Moreover, the sustained virological response rate differed significantly between the educated group and the group not educated by the pharmacist. Adherence to the recommended doses of the drugs during the initial period (first 12 weeks) of treatment is important for the efficacy of pegylated-interferon therapy. The educational intervention prior to the treatment may have raised the SVR rate. Also, a single session of the pharmacist-initiative education may be expected to compensate for the shortage of physicians and be cost effective.
- 日本医療薬学会の論文
日本医療薬学会 | 論文
- O17-003 視覚障害者に対する手技指導の標準化を目的とした視覚障害擬似体験インスリン注射院内実習(一般演題 口頭発表,糖尿病/後発医薬品,医療薬学の創る未来 科学と臨床の融合)
- 20H-16 Basal-Bolus療法におけるインスリンデテミルの有効性(使用状況調査・意識調査,来るべき時代への道を拓く)
- 30-P2-43 2種類のインスリン試薬を用いた化学発光酵素免疫測定法によってFactitious hypoglicemiaを証明しえた一例(副作用・有害事象,社会の期待に応える医療薬学を)
- 28-04-20 ペン型インスリン注射器の精度に及ぼす注入時抵抗とカートリッジ内気泡の影響
- P-610 ファブリー病に対する「ファブラザイム^[○!R]」投与時の「過敏反応発現時の対処方法」の一部改変により副作用防止に至った1症例(8.有害事象・副作用(基礎と臨床)1,医療薬学の未来へ翔(はばた)く-薬剤師の薬剤業務・教育・研究への能動的関わり-)